Skip to Main Content

Author Details

Deena M A Gendoo
Institute of Cancer and Genomic Sciences, University of Birmingham
2008
28
17
PMIDPaper TitleJournal TitlePublished Year
36227548Overview of Bioinformatics Software and Databases for Metabolic Engineering.Methods Mol Biol2023
36227548Overview of Bioinformatics Software and Databases for Metabolic Engineering.Methods Mol Biol2023
36650051A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements.Genome Res2023
36650051A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements.Genome Res2023
36280687Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.Nat Commun2022
36280687Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.Nat Commun2022
33359448The anti-tumour activity of DNA methylation inhibitor 5-aza-2'-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress.Cancer Lett2021
33359448The anti-tumour activity of DNA methylation inhibitor 5-aza-2'-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress.Cancer Lett2021
32286280Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.Nat Commun2020
32128067Bioinformatics and computational approaches for analyzing patient-derived disease models in cancer research.Comput Struct Biotechnol J2020
32286280Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.Nat Commun2020
32128067Bioinformatics and computational approaches for analyzing patient-derived disease models in cancer research.Comput Struct Biotechnol J2020
30629588Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer.PLoS Comput Biol2019
30629588Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer.PLoS Comput Biol2019
30704524A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.Breast Cancer Res2019
31217513MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature.Sci Rep2019
31217513MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature.Sci Rep2019
30704524A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.Breast Cancer Res2019
29476017Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.Clin Cancer Res2018
30084834Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.Clin Cancer Res2018
29476017Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.Clin Cancer Res2018
30084834Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.Clin Cancer Res2018
27861902The molecular basis of breast cancer pathological phenotypes.J Pathol2017
27861902The molecular basis of breast cancer pathological phenotypes.J Pathol2017
28314784Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy.Cancer Res2017
28314784Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy.Cancer Res2017
27069505MM2S: personalized diagnosis of medulloblastoma patients and model systems.Source Code Biol Med2016
27069505MM2S: personalized diagnosis of medulloblastoma patients and model systems.Source Code Biol Med2016
26656004PharmacoGx: an R package for analysis of large pharmacogenomic datasets.Bioinformatics2016
26607490Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.Bioinformatics2016
26463000Public data and open source tools for multi-assay genomic investigation of disease.Brief Bioinform2016
27960086Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.Cancer Cell2016
26463000Public data and open source tools for multi-assay genomic investigation of disease.Brief Bioinform2016
26656004PharmacoGx: an R package for analysis of large pharmacogenomic datasets.Bioinformatics2016
26607490Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.Bioinformatics2016
27960086Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.Cancer Cell2016
25689980Medulloblastoma subgroups remain stable across primary and metastatic compartments.Acta Neuropathol2015
25619596The first small-molecule inhibitors of members of the ribonuclease E family.Sci Rep2015
25689980Medulloblastoma subgroups remain stable across primary and metastatic compartments.Acta Neuropathol2015
26363007CD73 is associated with poor prognosis in high-grade serous ovarian cancer.Cancer Res2015
26168261Erratum: The First Small-Molecule Inhibitors of Members of the Ribonuclease E Family.Sci Rep2015
25979459Personalized diagnosis of medulloblastoma subtypes across patients and model systems.Genomics2015
26363007CD73 is associated with poor prognosis in high-grade serous ovarian cancer.Cancer Res2015
26168261Erratum: The First Small-Molecule Inhibitors of Members of the Ribonuclease E Family.Sci Rep2015
25979459Personalized diagnosis of medulloblastoma subtypes across patients and model systems.Genomics2015
25619596The first small-molecule inhibitors of members of the ribonuclease E family.Sci Rep2015
22363733PrionHome: a database of prions and other sequences relevant to prion phenomena.PLoS One2012
22912570The landscape of the prion protein's structural response to mutation revealed by principal component analysis of multiple NMR ensembles.PLoS Comput Biol2012
22363733PrionHome: a database of prions and other sequences relevant to prion phenomena.PLoS One2012
22912570The landscape of the prion protein's structural response to mutation revealed by principal component analysis of multiple NMR ensembles.PLoS Comput Biol2012
  • 1 - 50 of 56

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 1
University of Florida.
Career Start Year 2013
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 9
University of Laval
Career Start Year 2007
Number of shared co-authors 0
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 9
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 1
University of Washington
Career Start Year 2006
Number of shared co-authors 6
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 16
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 0
Ulsan National Institute of Science and Technology (UNIST)
Career Start Year 2005
Number of shared co-authors 8
MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Washington University
Career Start Year 2003
Number of shared co-authors 5
Oregon Health & Science University
Career Start Year 2003
Number of shared co-authors 0
Washington University
Career Start Year 2003
Number of shared co-authors 6
Cystic Fibrosis Foundation
Career Start Year 2003
Number of shared co-authors 3
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 3
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 6
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 10
Spanish National Cancer Research Centre-CNIO
Career Start Year 2002
Number of shared co-authors 1
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 2
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 4
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 3
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 12
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 25
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 8
Columbia University
Career Start Year 1993
Number of shared co-authors 3
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2

Collaborators

Princess Margaret Cancer Centre, University Health Network
Co-authored papers 15
University of Pennsylvania
Co-authored papers 4
Princess Margaret Cancer Center, University Health Network
Co-authored papers 4
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 3
Princess Margaret Cancer Research Centre
Co-authored papers 3
The Hospital for Sick Children
Co-authored papers 3
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers 3
University of Toronto
Co-authored papers 3
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Co-authored papers 3
City University of New York School of Public Health
Co-authored papers 3
Hospital for Sick Children
Co-authored papers 2
University of Toronto
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
College of Pharmaceutical Sciences, Shanghai Jiao Tong University
Co-authored papers 2
The Hospital for Sick Children
Co-authored papers 2
Hospital for Sick Children
Co-authored papers 2
Virginia Commonwealthy University
Co-authored papers 2
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 2
NYU School of Medicine
Co-authored papers 2
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Co-authored papers 2
The Hospital for Sick Children
Co-authored papers 2
SickKids Research Institute
Co-authored papers 2
McGill University
Co-authored papers 1
Co-authored papers 1
Northwestern University
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Lineberger Cancer Center, University of North Carolina
Co-authored papers 1
Heersink School of Medicine, The University of Alabama at Birmingham
Co-authored papers 1
Center for Computational Biomedicine, Harvard Medical School
Co-authored papers 1
Co-authored papers 1